Treatment strategies for cryptococcal infection: challenges, advances and future outlook

KR Iyer, NM Revie, C Fu, N Robbins… - Nature Reviews …, 2021 - nature.com
Cryptococcus spp., in particular Cryptococcus neoformans and Cryptococcus gattii, have an
enormous impact on human health worldwide. The global burden of cryptococcal meningitis …

Combatting the evolution of antifungal resistance in Cryptococcus neoformans

A Bermas, J Geddes‐McAlister - Molecular microbiology, 2020 - Wiley Online Library
Fungal infections are a global concern and the evolution of intrinsic resistance to current
antifungals presents an alarming problem. For Cryptococcus neoformans, a human fungal …

Present and Future Therapy of Cryptococcus Infections

A Mourad, JR Perfect - Journal of fungi, 2018 - mdpi.com
Cryptococcal infections burden the immunocompromised population with unacceptably high
morbidity and mortality. This population includes HIV-infected individuals and those …

Cryptococcal therapies and drug targets: the old, the new and the promising

C Coelho, A Casadevall - Cellular microbiology, 2016 - Wiley Online Library
Half a century after the introduction of Amphotericin B the management of cryptococcosis
remains unsatisfactory. The disease, caused primarily by the two fungal species …

Epidemiology and management of cryptococcal meningitis: developments and challenges

R Pukkila-Worley, E Mylonakis - Expert opinion on …, 2008 - Taylor & Francis
The significance of cryptococcal infection as a cause of human disease has dramatically
evolved in recent years. The objective of this study was to outline the worldwide significance …

Cryptococcus: from environmental saprophyte to global pathogen

RC May, NRH Stone, DL Wiesner, T Bicanic… - Nature Reviews …, 2016 - nature.com
Cryptococcosis is a globally distributed invasive fungal infection that is caused by species
within the genus Cryptococcus which presents substantial therapeutic challenges. Although …

Treatment of cryptococcosis in non-HIV immunocompromised patients

AF Henao-Martínez, DB Chastain… - Current Opinion in …, 2018 - journals.lww.com
Cryptococcus spp. conveys a high disease burden among immunocompromised hosts.
Clinicians must consider numerous variables and factors in a dynamic way to offer the best …

A titanic drug resistance threat in Cryptococcus neoformans

H Zafar, S Altamirano, ER Ballou, K Nielsen - Current opinion in …, 2019 - Elsevier
Increasing resistance to frontline antifungals is a growing threat to global health. In the face
of high rates of relapse for patients with cryptococcal meningitis and frequent drug …

A repurposing approach identifies off-patent drugs with fungicidal cryptococcal activity, a common structural chemotype, and pharmacological properties relevant to …

A Butts, L DiDone, K Koselny, BK Baxter… - Eukaryotic …, 2013 - Am Soc Microbiol
New, more accessible therapies for cryptococcosis represent an unmet clinical need of
global importance. We took a repurposing approach to identify previously developed drugs …

Cryptococcosis

AC Gushiken, KK Saharia, JW Baddley - Infectious Disease Clinics, 2021 - id.theclinics.com
Cryptococcosis is an infection of global significance, affecting both immunocompromised
and immunocompetent hosts. Traditionally, 2 main species of yeasts caused cryptococcosis …